- Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung trans-
plantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144(3 pt 1):552–556. - Mun ̃oz P, Palomo J, Guembe P, et al. Lung nodular lesions in heart transplant recipients. J Heart
Lung Transplant 2000; 19(7):660–667. - Mun ̃oz P, Rodriguez C, Bouza E, et al. Risk factors of invasive aspergillosis after heart
transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant 2004; 4(4):636–643. - Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the
1990s. Transplantation 1997; 64(5):716–720. - Singh N, Gayowski T, Wagener MM, et al. Invasive fungal infections in liver transplant recipients
receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997; 24(2):179–184. - Mun ̃oz P, Burillo A, Bouza E. Environmental surveillance and other control measures in the
prevention of nosocomial fungal infections. Clin Microbiol Infect 2001; 7(suppl 2):38–45. - Gavalda J, Len O, San Juan R, et al. Risk factors for invasive aspergillosis in solid-organ transplant
recipients: a case-control study. Clin Infect Dis 2005; 41(1):52–59. - Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine 1999; 78(2):123–138.
- Mun ̃oz P, Singh N, Bouza E. Treatment of solid organ transplant patients with invasive fungal
infections: should a combination of antifungal drugs be used? Curr Opin Infect Dis 2006; 19(4):
365–370. - Husain S, Alexander BD, Mun ̃oz P, et al. Opportunistic mycelial fungal infections in organ
transplant recipients: emerging importance of non-Aspergillusmycelial fungi. Clin Infect Dis 2003;
37(2):221–229. - Husain S, Mun ̃oz P, Forrest G, et al. Infections due toScedosporium apiospermumandScedosporium
prolificansin transplant recipients: clinical characteristics and impact of antifungal agent therapy on
outcome. Clin Infect Dis 2005; 40(1):89–99. - Mun ̃oz P, Mun ̃oz RM, Palomo J, et al.Pneumocystis cariniiinfection in heart transplant recipients.
Efficacy of a weekend prophylaxis schedule. Medicine (Baltimore) 1997; 76(6):415–422. - Rapose A, Lick SD, Ismail N.Listeria grayibacteremia in a heart transplant recipient. Transpl Infect
Dis 2008; 10(6):434–436. - Singh N, Lortholary O, Alexander BD, et al. Antifungal management practices and evolution of
infection in organ transplant recipients withCryptococcus neoformansinfection. Transplantation 2005;
80(8):1033–1039. - Singh N, Lortholary O, Alexander BD, et al. Allograft loss in renal transplant recipients with
Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 2005;
80(8):1131–1133. - el-Ebiary M, Torres A, Fabregas N, et al. Significance of the isolation ofCandidaspecies from
respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic
study. Am J Respir Crit Care Med 1997; 156(2 pt 1):583–590. - Park KY, Park CH.Candidainfection in a stent inserted for tracheal stenosis after heart lung
transplantation. Ann Thorac Surg 2005; 79(3):1054–1056. - Palmer SM, Perfect JR, Howell DN, et al. Candidal anastomotic infection in lung transplant
recipients: successful treatment with a combination of systemic and inhaled antifungal agents.
J Heart Lung Transplant 1998; 17(10):1029–1033. - Grossi P, Farina C, Fiocchi R, et al. Prevalence and outcome of invasive fungal infections in 1,963
thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of
Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000; 70(1):112–116. - Horvath J, Dummer S, Loyd J, et al. Infection in the transplanted and native lung after single lung
transplantation. Chest 1993; 104(3):681–685. - Sun Q, Li L, Ji S, et al. Variation of CD4+ and CD8+ T lymphocytes as predictor of outcome in renal
allograft recipients who developed acute respiratory distress syndrome caused by cytomegalovirus
pneumonia. Transplant Proc 2005; 37(5):2118–21121. - Liebau P, Kuse E, Winkler M, et al. Management of herpes simplex virus type 1 pneumonia
following liver transplantation. Infection 1996; 24(2):130–135. - Weiss RL, Colby TV, Spruance SL, et al. Simultaneous cytomegalovirus and herpes simplex virus
pneumonia. Arch Pathol Lab Med 1987; 111(3):242–245. - Friedrichs N, Eis-Hubinger AM, Heim A, et al. Acute adenoviral infection of a graft by serotype
35 following renal transplantation. Pathol Res Pract 2003; 199(8):565–570. - Wright JJ, O’Driscoll G. Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant
recipient with intravenous ribavirin and methylprednisolone. J Heart Lung Transplant 2005;
24(3):343–346. - Kumar D, Humar A. Emerging viral infections in transplant recipients. Curr Opin Infect Dis 2005;
18(4):337–341.
412 Mun ̃oz et al.